4//SEC Filing
Deferiere Raphael 4
Accession 0001847903-25-000086
CIK 0001847903other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 4:26 PM ET
Size
5.9 KB
Accession
0001847903-25-000086
Insider Transaction Report
Form 4
Deferiere Raphael
Chief Accounting Officer
Transactions
- Award
Share Option (right to buy)
2025-06-02+165,000→ 165,000 totalExercise: $13.41Exp: 2035-06-02→ Ordinary Shares (165,000 underlying)
Footnotes (2)
- [F1]25% of the shares subject to such option shall vest and become exercisable on June 2, 2026 and the remaining 75% of the shares subject to such option shall vest and become exercisable in 36 monthly installments on the first day of each month thereafter.
- [F2]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Documents
Issuer
Centessa Pharmaceuticals plc
CIK 0001847903
Entity typeother
Related Parties
1- filerCIK 0002071320
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 4:26 PM ET
- Size
- 5.9 KB